PRINIVIL

Compare PRINIVIL  to:
Compare
Compare

Generic Name for PRINIVIL

Lisinopril 2.5mg, 5mg+, 10mg, 20mg, 40mg; tabs; +scored.

Legal Classification:

Rx

Pharmacological Class for PRINIVIL

ACE inhibitor.

Manufacturer of PRINIVIL

Merck & Co., Inc.

Indications for PRINIVIL

Hypertension.

Adult dose for PRINIVIL

Initially and if not on diuretics: 10mg once daily. Usual range: 20–40mg once daily. If on diuretic: suspend diuretic for 2–3 days before starting; resume diuretic if BP not controlled by lisinopril alone. If diuretic cannot be discontinued: initially 5mg daily (supervise 1st dose). CrCl 10–30mL/min: initially 5mg daily; CrCl <10mL/min: initially 2.5mg daily; max 40mg daily.

Children's dosing for PRINIVIL

<6yrs or CrCl <30mL/min/1.73m2: not recommended. ≥6yrs: initially 0.07mg/kg (max 5mg) once daily; usual max 0.61mg/kg (40mg) once daily.

Contraindications for PRINIVIL

History of ACEI-associated or other angioedema. Pregnancy (Cat.D in 2nd and 3rd trimesters).

Warnings/Precautions for PRINIVIL

Renal impairment. Dialysis (esp. high-flux membrane). Salt/volume depletion. Hypertrophic cardiomyopathy. CHF. Ischemic heart disease. Cerebrovascular disease. Renal artery stenosis. Surgery. Monitor renal function, serum potassium in diabetics. Monitor WBCs in renal and collagen vascular disease patients. Discontinue immediately if angioedema or laryngeal edema occurs (have SC epinephrine available). Elderly. Pregnancy (Cat.C in 1st trimester). Nursing mothers: not recommended.

Interactions for PRINIVIL

May cause hypotension or increased BUN with diuretics, hyperkalemia with K+ sparing diuretics or K+ supplements. May increase lithium levels; monitor frequently. Antagonized by, and increased risk of renal failure with, NSAIDs.

Adverse Reactions for PRINIVIL

Dizziness, headache, fatigue, diarrhea, upper respiratory symptoms, cough, nausea, hyperkalemia, orthostatic hypotension, renal impairment, angioedema; liver dysfunction, blood dyscrasias (rare).

How is PRINIVIL supplied?

Tabs 2.5mg—30, 100
Tabs 5mg—90, 100, 1000
Tabs 10mg, 20mg—30, 90, 100, 1000
Tabs 40mg—100

Related Disease:

Hypertension

Related Resources

Tekamlo approved for hypertension

August 27, 2010

The FDA has approved Tekamlo (aliskiren and amlodipine tablets, from Novartis), a single, combination therapy tablet for the treatment of hypertension, alone or with other antihypertensive agents.

Tribenzor approved for treatment of hypertension

July 26, 2010

Daiichi Sankyo announced that the FDA has approved Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide tablets), a fixed-dose combination therapy for the treatment of hypertension in patients who are not adequately controlled on any two of the following antihypertensive drug classes: angiotensin receptor blockers, calcium channel blockers, and diuretics.

FDA warns of dangerous ingredients in Joyful Slim herb supplement

July 22, 2010

The FDA is warning consumers that Joyful Slim herb supplement, marketed as a natural herb for weight loss, contains undeclared desmethyl sibutramine, an FDA-approved drug used as an appetite suppressant for weight loss.

FDA conducts safety review of cancer risk with angiotensin receptor blockers (ARBs)

July 15, 2010

A recently published meta-analysis combining cancer-related findings from several clinical trials is suggesting that angiotensin receptor blockers (ARBs) may be associated with a small increased risk of cancer.

FDA reviews cardiovascular mortality risk associated with Benicar

June 11, 2010

The FDA is evaluating data from two clinical trials in which patients with type 2 diabetes taking Benicar (olmesartan medoxomil tablets, from Daiichi Sankyo) had a higher rate of death from a cardiovascular cause compared to patients taking a placebo.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions